Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
gptkb:Weyland_Corporation
|
| gptkbp:associated_with |
gptkb:Alien_franchise
|
| gptkbp:challenges |
ethical concerns
|
| gptkbp:collaborates_with |
other biotech firms
|
| gptkbp:employees |
gptkb:physicist
|
| gptkbp:founded |
gptkb:Peter_Weyland
21st century |
| gptkbp:headquarters |
Weyland Corporation Headquarters
|
| https://www.w3.org/2000/01/rdf-schema#label |
Weyland Bioengineering
|
| gptkbp:industry |
gptkb:Company
|
| gptkbp:influences |
gptkb:Author
|
| gptkbp:location |
gptkb:physicist
|
| gptkbp:motto |
nan
|
| gptkbp:notable_for |
advanced genetic engineering
|
| gptkbp:operates_in |
gptkb:spacecraft
|
| gptkbp:parent_company |
gptkb:Weyland_Corporation
|
| gptkbp:products |
genetically modified organisms
|
| gptkbp:research_focus |
human enhancement
|
| gptkbp:technology |
bioprinting
|
| gptkbp:vision |
improving human life
|
| gptkbp:bfsParent |
gptkb:Weyland_Corporation
gptkb:Weyland_Industries gptkb:the_Weyland_Corporation |
| gptkbp:bfsLayer |
5
|